We are monitoring the impact of COVID-19 & Recession alarm on North America CRO Services Market Get in touch with us for detailed analysis Know More

Know More

Share on

North America CRO Services Market Research Report - Segmented By Type, End User, Country (United States, Canada and Rest of North America) - Industry Size, Share, Growth, Trends and Forecast (2022 to 2027)

Published: January, 2022
ID: 6963
Pages: 145

North America CRO Services Market Size (2022 to 2027)

The size of the Contract Research Organization (CRO) Services Market in North America is anticipated to grow at a 6.02% CAGR from 2022 to 2027. It is estimated that the North American market was valued at USD 14.67 billion in 2022 and is expected to reach USD 19.65 billion by 2027.

Y-O-Y growth in the prevalence of chronic diseases such as cardiovascular, diabetes, and oncology demands more innovative treatment therapies, which is estimated to add a boost to the growth of the market. The majority of the Americans are suffering from cardiovascular diseases providing considerable segment opportunities in the market, according to Heart Disease and Stroke Statistics, 2017. Growing investments in healthcare by both private and public organizations is escalating the demand of the market. The intensity for research and development by the companies in the United States is accounted for around 17%, rise in the aging population, Y-O-Y growth in the incidence of chronic diseases, infectious and non-communicable conditions are anticipated to propel the demand of this market.

The shortage of qualified scientists and difficulties in appointing experienced employees for particular projects may restrain the region's CRO services market growth. Strict regulations for the approval of the drugs and products may hinder the market.

This research report on the North America CRO Services Market has been segmented & sub-segmented into the following categories:

North America CRO Services Market - By Type:

  • Clinical Research Services                
  • Phase I Clinical Research Services              
  • Phase II Clinical Research Services             
  • Phase III Clinical Research Services           
  • Phase IV Clinical Research Services           
  • Early-Phase Development Services                              
  • Discovery Studies             
  • Chemistry, Manufacturing, & Control (CMC)        
  • Preclinical Services           
    • Pharmacokinetics/Pharmacodynamics (PK/PD)
    • Toxicology Testing Services
    • Other Preclinical Services
  • Laboratory Services                             
  • Bioanalytical Testing Services      
  • Analytical Testing Services            
    • Physical Characterization
    • Raw Material Testing
    • Batch-Release Testing
    • Stability Testing
    • Other Analytical Testing Services
  • Consulting Services                

North America CRO Services Market – By Therapeutic Area

  • Oncology
  • CNS
  • Cardiovascular    

North America CRO Services Market – By End User

  • Pharmaceutical
  • Biopharmaceutical
  • Medical Device Companies

North America CRO Services Market – By Country

  • United States
  • Canada
  • Rest of North America

Regionally, North America held the largest share in the global market. The large share of this regional segment can be attributed to the high-quality pharmaceutical industry standards, rapid growth in the biosimilars and biologics market, a surge in demand for outsourcing of services by pharmaceutical and biopharmaceutical companies, and a rise in the number of clinical trials in this region. Furthermore, the U.S. government's massive investment in R & D of medical care is further expected to boost the market.

The North American Contract Research Organization (CRO) Services Market is mainly dominated by companies such as Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Type                                              

                                5.1.1 Introduction                           

                                5.1.2 Clinical Research Services                 

                                                5.1.2.1 Phase I Clinical Research Services              

                                                5.1.2.2 Phase II Clinical Research Services             

                                                5.1.2.3 Phase III Clinical Research Services           

                                                5.1.2.4 Phase IV Clinical Research Services           

                                5.1.3 Early-Phase Development Services                              

                                                5.1.3.1 Discovery Studies             

                                                5.1.3.2 Chemistry, Manufacturing, & Control (CMC)        

                                                5.1.3.3 Preclinical Services           

                                                                5.1.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)

                                                                5.1.3.3.2 Toxicology Testing Services

                                                                5.1.3.3.3 Other Preclinical Services

                                5.1.4 Laboratory Services                             

                                                5.1.4.1 Bioanalytical Testing Services      

                                                5.1.4.2 Analytical Testing Services            

                                                                5.1.4.2.1 Physical Characterization

                                                                5.1.4.2.2 Raw Material Testing

                                                                5.1.4.2.3 Batch-Release Testing

                                                                5.1.4.2.4 Stability Testing

                                                                5.1.4.2.5 Other Analytical Testing Services

                                5.1.5 Consulting Services                             

                                5.1.6 Y-o-Y Growth Analysis, By Product                               

                                5.1.7  Market Attractiveness Analysis, By Product                            

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Therapeutic Area                                     

                                5.2.1 Introduction                           

                                5.2.2 Oncology                 

                                5.2.3 CNS                            

                                5.2.4 Cardiovascular                       

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic Area                            

                                5.2.6 Market Attractiveness Analysis, By Therapeutic Area                          

                                5.2.7 Market Share Analysis, By Therapeutic Area                            

                5.3 End User                                      

                                5.3.1 Introduction                           

                                5.3.2 Pharmaceutical                     

                                5.3.3 Biopharmaceutical                               

                                5.3.4 Medical Device Companiest                            

                                5.3.5 Y-o-Y Growth Analysis, By End User                             

                                5.3.6  Market Attractiveness Analysis, By End User                          

                                5.3.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Therapeutic Area        

                                                6.1.3.3 By Type 

                                                6.1.3.4 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Therapeutic Area        

                                                6.1.4.3 By End User        

                                                6.1.4.4 By Application    

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Therapeutic Area        

                                                6.1.5.3 By Type 

                                                6.1.5.4 By End User        

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Quintiles Transnational Holdings Inc.                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Laboratory Corporation of America Holdings                                               

                8.3 Pharmaceutical Product Development                                           

                8.4 PAREXEL International Corporation                                  

                8.5 ICON Plc                                       

                8.6 PRA Health Sciences Inc.                                       

                8.7 InVentiv Health Inc.                                

                8.8 Charles River Laboratories International Inc.                                

                8.9 INC Research Holdings Inc.                                  

                8.10 Wuxi PharmaTech.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. North America Contract Research Organization Services Market, By Type, From 2022 - 2027 (USD Billion)
  2. North America Preclinical Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America Clinical Research Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Laboratory Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Contract Research Organization Services Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  6. North America Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America CNS Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  9. North America Contract Research Organization Services Market, By End User, From 2022 - 2027 (USD Billion)
  10. North America Pharmaceutical Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Biopharmaceutical Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Medical Device Companie Market, By Region, From 2022 - 2027 (USD Billion)
  13. United States Contract Research Organization Services Market, By Type, From 2022 - 2027 (USD Billion)
  14. United States Contract Research Organization Services Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  15. United States Contract Research Organization Services Market, By End User, From 2022 - 2027 (USD Billion)
  16. Canada Contract Research Organization Services Market, By Type, From 2022 - 2027 (USD Billion)
  17. Canada Contract Research Organization Services Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  18. Canada Contract Research Organization Services Market, By End User, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample